Myeloid Leukemia — Trials

Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

3,530 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 862
Recruiting: 498
Ph III recruiting: 47
Growth YoY: +2.9%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (619)

clinicaltrialsPublishedShowing 151–200 of 1,437 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07155382	Allogeneic HCT Using Conditioning Regimen of BuFluATG for AML CR1	completed	—	98	Asan Medical CenterOTHER	1	Sep 4, 2025	clinicaltrials
NCT07151820	A Real-world Study About the Impact of Adverse Events (AEs) on Treatment Adjustments, Healthcare Resource Use, and Costs Among Chronic Myeloid Leukemia Patients	completed	—	2,546	Novartis PharmaceuticalsINDUSTRY	1	Sep 3, 2025